On October 9, Glenmark Lifesciences declared an interim dividend of Rs 22.50 per share, the firm told exchanges.
The record date for reckoning the list of shareholders who shall be eligible to receive the stated interim dividend shall be Tuesday, October 17, 2023, as informed in our letter of October 04, 2023, the business stated in its filing with the bourses.
The stockholders will get the interim dividend on or after October 23, 2023.
Glenmark Lifesciences made headlines lately after Glenmark Pharmaceuticals sold a 75% stake in the company for Rs 5,651 crore.
Glenmark Pharmaceuticals, with eight medicines in various phases of clinical development, is a leader in the discovery of new molecules, both NCEs (new chemical entities) and NBEs (new biological entities).
For feedback and suggestions, write to us at editorial@iifl.com
Related Tags
Invest wise with Expert advice
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
IIFL Securities Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.